Oseong Advanced Materials "Publication in Clinical Journal on Neuroprotection Using CBD"

[Asia Economy Reporter Hyunseok Yoo] Oseong Advanced Materials announced on the 25th that the research paper on medical cannabis, "Neuroprotective Effect of Cannabidiol Against Hydrogen Peroxide in Hippocampal Neuron Culture," promoted through its 100% subsidiary Cannabis Medical, has been published in the global academic journal "Cannabis and Cannabinoid Research."

The journal "Cannabis and Cannabinoid Research," in which this paper was published, is known as the most authoritative academic journal dedicated to the scientific, medical, and psychosocial exploration and biochemical mechanisms of cannabis. According to the company, "Cannabis and Cannabinoid Research" is also used as the official journal by cannabis-related social organizations such as ICRS (International Cannabinoid Research Society), SCC (The Society of Cannabis Clinicians), and IACM (the International Association of Cannabinoid Medicines).

The published paper includes the research process, evidence, and conclusions verifying that CBD, a cannabis extract, has a significant effect in neutralizing neurotoxicity on major hippocampal neurons closely related to the initiation or progression of neurodegenerative brain diseases.

A representative of Oseong Advanced Materials stated, "This case is an example where clinical data on the neuroprotective ability of CBD secured through the medical cannabis research and development project has been officially recognized by publication in a global academic journal," adding, "As this is the world's first case verifying the medical efficacy of CBD, which has been unofficially mentioned so far, we plan to apply and utilize it in various fields in the future."

The company plans to actively promote brain disease prevention-related businesses based on this achievement, as the medical efficacy of CBD has been officially verified. These include ▲ hemp food and beverages ▲ health supplements for patients with brain diseases such as dementia ▲ and the launch of foods for the prevention of Parkinson's, Lou Gehrig's disease, and dementia using extracted CBD components.

Since 2018, Oseong Advanced Materials has been investing in research and development utilizing medical cannabis in collaboration with Professor Choi Inseong's team at the Korea Advanced Institute of Science and Technology (KAIST) through its subsidiary Cannabis Medical. Oseong Advanced Materials is a subsidiary of S-Mac, which is expanding its business by participating in rare earth projects in the United States. Last month, S-Mac acquired an additional 8 million shares of Oseong Advanced Materials, raising its total stake to 13.85%, becoming the largest shareholder.

This content was produced with the assistance of AI translation services.